From commissioning to clinical routine: RadCalc Monte Carlo on Halcyon across 2,385 plans
Join the webinar to gain practical insights into commissioning RadCalc Monte Carlo on Halcyon and learn how statistical process control was used to determine institution-specific QA limits based on 2,385 patient plans.
At Uniklinik Köln, the Department of Radiation Oncology commissioned RadCalc Monte Carlo as an independent secondary dose verification system for its Halcyon platform.
In this webinar, PD Dr. Florian Kamp shares practical experience with the commissioning and clinical evaluation of RadCalc Monte Carlo.
The webinar follows the complete journey from depth-dose, cross-profile and point-dose measurements to Monte Carlo beam model tuning and subsequent clinical evaluation.
A particular focus is placed on the analysis of 2,385 patient plans using gamma analysis and on how statistical process control was used to determine institution-specific tolerance and action limits.
Webinar details
- Day: Thursday, October 15, 2026
- Time: 3 p.m. CEST
- Language: English
- Location: Online – free to attend
Key learnings
- The full commissioning workflow for RadCalc Monte Carlo on Halcyon including the final beam model parameters.
- How universal and institution-specific gamma limits compare including the comparison of AAPM TG-219 default gamma limits with statistically derived limits for the tighter 2%/2 mm criterion.
- How gamma passing rates can differ between sites and what these differences can mean for clinical decision-making.
